Title : SM03, an anti-human CD22 monoclonal antibody, for active rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled study.

Pub. Date : 2022 May 5

PMID : 34508557






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SM03, an anti-human CD22 monoclonal antibody, for active rheumatoid arthritis: a phase II randomized, double-blind, placebo-controlled study. sm03 CD22 molecule Homo sapiens